Skewing X chromosome choice by modulating sense transcription across the Xist locus

  1. Tatyana B. Nesterova1,
  2. Colette M. Johnston1,3,
  3. Ruth Appanah1,
  4. Alistair E.T. Newall1,4,
  5. Jonathan Godwin2,
  6. Maria Alexiou2, and
  7. Neil Brockdorff1,5
  1. 1 X Inactivation Group, MRC Clinical Sciences Centre, Faculty of Medicine ICSTM, Hammersmith Hospital, London, W12 0NN, UK
  2. 2 Transgenic Facility, MRC Clinical Sciences Centre, Faculty of Medicine ICSTM, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK

Abstract

The X-inactive-specific transcript (Xist) locus is a cis-acting switch that regulates X chromosome inactivation in mammals. Over recent years an important goal has been to understand how Xist is regulated at the initiation of X inactivation. Here we report the analysis of a series of targeted mutations at the 5′ end of the Xist locus. A number of these mutations were found to cause preferential inactivation, to varying degrees, of the X chromosome bearing the targeted allele in XX heterozygotes. This phenotype is similar to that seen with mutations that ablate Tsix, an antisense RNA initiated 3′ of Xist. Interestingly, each of the 5′ mutations causing nonrandom X inactivation was found to exhibit ectopic sense transcription in embryonic stem (ES) cells. The level of ectopic transcription was seen to correlate with the degree of X inactivation skewing. Conversely, targeted mutations which did not affect randomness of X inactivation also did not exhibit ectopic sense transcription. These results indicate that X chromosome choice is determined by the balance of Xist sense and antisense transcription prior to the onset of random X inactivation.

Keywords

Footnotes

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.271203.

  • 3 Present address: Chromatin and Gene Expression Group, The Babraham Institute, Babraham CB2 4AT, Cambridgeshire, UK

  • 4 Present address: Human Cytogenetics Group, Cancer Research UK, Lincoln's Inn Fields Laboratories, 44 Lincoln's Inn Field, London WC2A3PX, UK.

  • 5 Corresponding author.

    5 E-MAIL neil.brockdorff{at}csc.mrc.ac.uk; FAX 44-208-383-8303.

    • Accepted June 27, 2003.
    • Received May 6, 2003.
| Table of Contents

Life Science Alliance